Bob Wilffert

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 8

Top Topics

Mycobacterium Tuberculosis

Tyrosine Kinase

Major Depressive Disorder

Top Venues

Human psychopharmacology

The American journal of drug and alcohol abuse

British journal of clinical pharmacology

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Tharcila V Chaves, Bob Wilffert, Zila van der Meer Sanchez
Overdoses and deaths related to the use of ketamine and its analogues: a systematic review. The American journal of drug and alcohol abuse (2022)
Lisanne M Geers, Taichi Ochi, Natalya M Vyalova, Innokentiy S Losenkov, Diana Z Paderina, Ivan V Pozhidaev, German G Simutkin, Nikolay A Bokhan, Bob Wilffert, Daniel J Touw, Anton J M Loonen, Svetlana A Ivanova
Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment-free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design. Human psychopharmacology (2021)
Ivan V Pozhidaev, Anastasiia S Boiko, Anton J M Loonen, Diana Z Paderina, Olga Yu Fedorenko, Gennadiy Tenin, Elena G Kornetova, Arkadiy V Semke, Nikolay A Bokhan, Bob Wilffert, Svetlana A Ivanova
Association of Cholinergic Muscarinic M4 Receptor Gene Polymorphism with Schizophrenia. The application of clinical genetics 13 (2020)
Olga Yu Fedorenko, Diana Z Paderina, Anton J M Loonen, Ivan V Pozhidaev, Anastasiia S Boiko, Elena G Kornetova, Nikolay A Bokhan, Bob Wilffert, Svetlana A Ivanova
Association of ANKK1 polymorphism with antipsychotic-induced hyperprolactinemia. Human psychopharmacology 35 (4) (2020)
Tharcila V Chaves, Bob Wilffert, Zila van der Meer Sanchez
The use of ketamine to cope with depression and post-traumatic stress disorder: A qualitative analysis of the discourses posted on a popular online forum. The American journal of drug and alcohol abuse 46 (5) (2020)
Lisanne M Geers, Ivan V Pozhidaev, Svetlana A Ivanova, Maxim B Freidin, Amand F Schmidt, Dan Cohen, Anastasiia S Boiko, Diana Z Paderina, Olga Yu Fedorenko, Arkadiy V Semke, Nikolay A Bokhan, Bob Wilffert, Jos G W Kosterink, Daan J Touw, Anton J M Loonen
Association between 8 P-glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug-induced hyperprolactinaemia. British journal of clinical pharmacology 86 (9) (2020)
Doti P Martono, Hiddo J Lambers Heerspink, Eelko Hak, Petra Denig, Bob Wilffert
No significant association of type 2 diabetes-related genetic risk scores with glycated haemoglobin levels after initiating metformin or sulphonylurea derivatives. Diabetes, obesity & metabolism 21 (10) (2019)
Min Zhang, Shuqiang Wang, Bob Wilffert, Rongsheng Tong, Dick van Soolingen, Susan van den Hof, Jan Willem C Alffenaar
The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis. British journal of clinical pharmacology 84 (12) (2018)